tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KURA Stock Latest News

Kura Oncology’s Strategic Milestones and Financial Strength Bolster Buy Rating
RatingsKura Oncology’s Strategic Milestones and Financial Strength Bolster Buy Rating
11d ago
KURA
Kura Oncology’s Promising Developments and Strategic Expansion Justify Buy Rating
PremiumRatings
Kura Oncology’s Promising Developments and Strategic Expansion Justify Buy Rating
12d ago
KURA
Strategic Advancements and Early NDA Submission Drive Buy Rating for Kura Oncology
PremiumRatings
Strategic Advancements and Early NDA Submission Drive Buy Rating for Kura Oncology
12d ago
KURA
Kura Oncology, Kyowa Kirin announce submission of NDA for ziftomenib to FDA
PremiumThe Fly
Kura Oncology, Kyowa Kirin announce submission of NDA for ziftomenib to FDA
12d ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
16d ago
KURA
Kura Oncology announces preclinical data for KO-2806 to be presented at AACR
PremiumThe FlyKura Oncology announces preclinical data for KO-2806 to be presented at AACR
25d ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
1M ago
KURA
Kura Oncology price target lowered to $14 from $27 at UBS
Premium
The Fly
Kura Oncology price target lowered to $14 from $27 at UBS
2M ago
KURA
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
PremiumCompany Announcements
Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
2M ago
KURA
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects
PremiumCompany Announcements
Kura Oncology’s Positive Earnings Call Highlights Progress and Prospects
2M ago
KURA
Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
2M ago
KURA
Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage
PremiumRatings
Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage
2M ago
KURA
Kura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating
PremiumRatingsKura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating
2M ago
KURA
Kura Oncology Advances Cancer Drug Development
Premium
Company Announcements
Kura Oncology Advances Cancer Drug Development
2M ago
KURA
Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements
Premium
Ratings
Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements
2M ago
KURA
Kura Oncology’s Strategic Advancements and Financial Health Drive Buy Rating
PremiumRatings
Kura Oncology’s Strategic Advancements and Financial Health Drive Buy Rating
2M ago
KURA
Kura Oncology reports Q4 EPS (22c), consensus (64c)
PremiumThe Fly
Kura Oncology reports Q4 EPS (22c), consensus (64c)
2M ago
KURA
Is KURA a Buy, Before Earnings?
PremiumPre-Earnings
Is KURA a Buy, Before Earnings?
2M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
2M ago
KURA
Kura Oncology price target raised to $36 from $34 at Wedbush
PremiumThe FlyKura Oncology price target raised to $36 from $34 at Wedbush
2M ago
JNJ
KURA
Kura Oncology drops 11% to $8.07 after leukemia update, BTIG downgrade
Premium
The Fly
Kura Oncology drops 11% to $8.07 after leukemia update, BTIG downgrade
2M ago
KURA
Scotiabank would buy Kura on weakness despite KOMET-001 uncertainty
Premium
The Fly
Scotiabank would buy Kura on weakness despite KOMET-001 uncertainty
2M ago
KURA
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >